Skip to main content
SpringerLink
Log in

A GLOBAL CONGRESS DIGEST ON IMMUNE-DIRECTED THERAPIES IN HODGKIN LYMPHOMA. Report from the International Symposium on Hodgkin lymphoma (ISHL12), 22nd–24th October 2022 (hybrid)

  • Congress Report ISHL 2022
  • Published:
memo - Magazine of European Medical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

A GLOBAL CONGRESS DIGEST ON IMMUNE-DIRECTED THERAPIES IN HODGKIN LYMPHOMA. Report from the International Symposium on Hodgkin lymphoma (ISHL12), 22nd–24th October 2022 (hybrid). memo 15 (Suppl 11), 205–212 (2022). https://doi.org/10.1007/s12254-023-00874-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12254-023-00874-5

Search

Navigation